QLT Announces Phase II Clinical Trial Results and Development Plans for the ... - CNNMoney.com (press release)
Posted by admin! / Under Blood Allergy Test
QLT Announces Phase II Clinical Trial Results and Development Plans for the ... CNNMoney.com (press release) The second drug candidate selected for the punctal plug delivery platform is olopatadine, an anti-allergy drug. Olopatadine is an active pharmaceutical ... |
Published on Wednesday 10th of March 2010 03:48:46 PM




